Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir Disproxil

Clinical trial NCT04903847 · UNKNOWN

Trial details

NCT number: NCT04903847
Sponsor: Thomas Benfield
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hiv HIV Infections HIV Lipodystrophy Osteoporosis Renal Insufficiency Weight Gain Obesity

Start date: 2021-02-02
Primary completion: 2023-02-02
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.